---
title: Orchestra BioMed | We bring medical innovations to life
description: We are a biomedical innovation company focused on developing transformative therapeutic products for large unmet clinical needs in procedure-based medicine
---

[![OBM_Logo_Orange_White_RGB-4](https://7401945.hs-sites.com/hubfs/OBM_Logo_Orange_White_RGB-4.png) ](https://7401945.hs-sites.com/)

**

**

Close

## We bring medical inn![o](https://7401945.hs-sites.com/hubfs/home-banner-orchestra-o.png)vations to life

# We are a biomedical innovation company...

accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies.

## ![Our Approach](https://7401945.hs-sites.com/hubfs/handshake.svg)Our Approach

Our partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products we develop.

[Learn More](https://7401945.hs-sites.com/our-approach)

## ![light bulb](https://7401945.hs-sites.com/hubfs/lightbulb.svg)Our Pipeline

Our pipeline is comprised of innovative therapeutic product candidates that we believe have the potential for value creation using our partnership-enabled business model.

[Learn More](https://7401945.hs-sites.com/pipeline)

## ![our people](https://7401945.hs-sites.com/hubfs/employees.svg)Our People

We are led by a highly accomplished, multidisciplinary management team and board of directors with extensive experience in all phases of therapeutic device development.

[Learn More](https://7401945.hs-sites.com/our-people)

## Our Technologies

Our two late-stage flagship technologies are designed to address large unmet needs associated with the treatment of hypertension, a significant risk factor for death worldwide and atherosclerotic artery disease, the leading cause of mortality worldwide.

![BackBeat CNT](https://7401945.hs-sites.com/hubfs/backbeat-cnt@1x.jpg)

### BackBeat Cardiac Neuromodulation Therapy™

BackBeat CNT™ (also known as atrioventricular interval modulation (AVIM) therapy) is an investigational patented bioelectronic treatment for hypertension that is designed to drive an immediate, substantial and persistent reduction in blood pressure while simultaneously modulating autonomic nervous system responses to maintain the reduction.

[Learn more](https://7401945.hs-sites.com/backbeat-cnt)

![Virtue SAB](https://7401945.hs-sites.com/hubfs/virtue-sab@1x.jpg)

### Virtue® Sirolimus AngioInfusion™ Balloon (SAB)

Virtue SAB is an investigational patented drug/device combination product candidate for the treatment of artery disease designed to deliver a proprietary extended release formulation of sirolimus, SirolimusEFR, during balloon angioplasty without the need for balloon coating or a permanent implant.

[Learn more](https://7401945.hs-sites.com/virtue-sab)

![key facts mobile](https://7401945.hs-sites.com/hubfs/key-facts-mobile-3.jpg) ![keyfacts desktop](https://7401945.hs-sites.com/hubfs/keyfacts-1-1.jpg)

![BackBeat CNT and Virtue SAB](https://7401945.hs-sites.com/hubfs/2-rollover.png)

![CNT, Sostenocel, Microporous Balloon Infusion System](https://7401945.hs-sites.com/hubfs/3-rollover.png)

![Heart Failure, Opthalmic Inflammation, BPH & Urethral Strictures, Osteoarthritis, Chronic Rhinosinusitis](https://7401945.hs-sites.com/hubfs/5-rollover-2-1-1.png)

Virtue® SAB is investigational and not commercially approved.

BackBeat CNT™ (also known as AVIM therapy) is investigational and not commercially approved.

[![Orchestra BioMed logo](https://7401945.hs-sites.com/hs-fs/hubfs/OBM_Logo_Orange_White_RGB.png?width=260&name=OBM_Logo_Orange_White_RGB.png) ](https://7401945.hs-sites.com/)

[**](https://twitter.com/orchestrabiomed) [**](https://www.linkedin.com/company/orchestra-biomed/)

---

 © 2026 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.  
 All other trademarks are trademarks of their respective owners.  
 SM-0020 Rev 01

[Disclaimer](https://7401945.hs-sites.com/disclaimer)